Chemed CHE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 32.4%-0.2pp | 32.5%-0.3pp | 32.9%-0.8pp | 33.6%-1.2pp | 34.8%-0.3pp | |
| Operating margin | 12.9%-0.5pp | 13.4%-0.5pp | 13.9%-0.8pp | 14.7%-0.9pp | 15.6%+0.6pp | |
| Net margin | 10.2%-0.3pp | 10.5%-0.5pp | 11%-0.5pp | 11.6%-0.8pp | 12.4%0.0pp | |
| EBITDA margin | 15.5%-0.4pp | 15.9%-0.5pp | 16.4%-0.8pp | 17.2%-0.9pp | 18.2%+0.5pp | |
| Free cash flow margin | 14.8%+2.0pp | 12.9%-1.4pp | 14.2%-0.5pp | 14.8%+2.1pp | 12.7%-2.5pp | |
| Returns | ||||||
| Return on equity | 25.6%+0.3pp | 25.3%+1.2pp | 24.1%0.0pp | 24.1%-2.0pp | 26.1%-1.0pp | |
| Return on assets | 15.9%-0.6pp | 16.5%+0.1pp | 16.4%-0.4pp | 16.8%-1.1pp | 17.9%-0.2pp | |
| Return on invested capital | 25.1%-1.9pp | 27%0.0pp | 27%-1.3pp | 28.3%-2.3pp | 30.6%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×0.0× | 1.6×+0.1× | 1.5×0.0× | 1.5×0.0× | 1.4×0.0× | |
| Inventory turnover | 229.1×+12.2× | 216.9×+29.6× | 187.3×+19.6× | 167.7×-7.7× | 175.4×+19.2× | |
| Liquidity | ||||||
| Current ratio | 0.9×-0.2× | 1.1×-0.3× | 1.4×-0.5× | 1.9×+0.1× | 1.7×+0.3× | |
| Quick ratio | 0.8×-0.2× | 1×-0.3× | 1.3×-0.5× | 1.8×+0.1× | 1.7×+0.3× | |
| Cash ratio | 0.1×-0.2× | 0.3×-0.2× | 0.4×-0.5× | 0.9×+0.3× | 0.6×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | 0.6×+0.4× | 0.2×+0.1× | 0×+0.3× | -0.2×-0.2× | -0.1×0.0× | |
| Interest coverage | 169.7×-23.6× | 193.3×-10.1× | 203.4×-13.8× | 217.2×-13.7× | 230.9×+25.1× | |
| Per Share | ||||||
| Book value per share | $61.94-8.5% | $67.73-9.4% | $74.72-8.3% | $81.51+1.8% | $80.04+8.6% | |
| Valuation | ||||||
| Market capitalization | $5.2B-13.9% | $6.04B-7.5% | $6.52B-20.0% | $8.15B-9.5% | $9.01B+13.5% | |
| Enterprise value | $5.42B-11.2% | $6.11B-6.6% | $6.54B-18.8% | $8.05B-10.3% | $8.98B+13.6% | |
| Price / earnings | 20×-2.7× | 22.8×-0.6× | 23.4×-4.7× | 28.1×-1.1× | 29.2×+2.9× | |
| Price / sales | 2×-0.3× | 2.4×-0.2× | 2.6×-0.7× | 3.2×-0.4× | 3.6×+0.4× | |
| Price / book | 6.1×0.0× | 6.2×+0.1× | 6.1×-0.7× | 6.8×-0.8× | 7.6×+0.5× | |
| EV / EBITDA | 13.8×-1.4× | 15.1×-0.6× | 15.7×-2.9× | 18.6×-1.3× | 19.9×+1.5× | |
| EV / sales | 2.1×-0.3× | 2.4×-0.2× | 2.6×-0.6× | 3.2×-0.4× | 3.6×+0.4× | |
| Free cash flow yield | 7.3%+1.9pp | 5.4%-0.1pp | 5.5%+1.0pp | 4.6%+1.1pp | 3.5%-1.1pp | |
| Earnings yield | 5%+0.6pp | 4.4%+0.1pp | 4.3%+0.7pp | 3.6%+0.1pp | 3.4%-0.4pp | |
| Dividend yield | 0.6%+0.1pp | 0.5%+0.1pp | 0.5%+0.1pp | 0.4%0.0pp | 0.3%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Chemed's profit margins?
- Chemed (CHE) runs a 32.4% gross margin and a 12.9% operating margin, with a 10.2% net margin.
- Where do Chemed's ratios come from?
- Every ratio is computed from Chemed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
